Document is current
Any future updates will be listed below
-
Authors
Hiura, Satoshi
Kuwasaki, Yuto
Nishikawa, Yosuke
Kimura, Takako
Yoshida, Sayaka
Nakayama, Makiko
Makino, Tomohiro
Ueno, Suguru
-
Funding
Funding for this research was provided by:
Daiichi-Sankyo
- License Information
-
More Information
Article History
Received: 5 March 2025
Accepted: 1 September 2025
First Online: 29 September 2025
Declarations
:
: SH, YK, YN, TK, SY, MN, TM and SU are employees of Daiichi Sankyo Co., Ltd. SH, YK, YN, TK, SY, MN and SU are inventors on a patent and patent application WO2024090458A1, entitled “Method for avoiding immune rejection using agonist for inhibitory KIR” that covers KIR agonist to evade immune rejection by NK cells. No funding other than from Daiichi Sankyo Co., Ltd. was obtained for this study. Other authors declare no conflict of interest.
